Chemed CorporationCHE
NYSE•Healthcare•Medical Care Facilities
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $2.54B, growing 2.1% year-over-year. TTM net income stood at $259.78M (15.9% contraction). Quarterly EBITDA was $101.45M and operating income was $84.58M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze CHE growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters